The field of precision medicine is undergoing a profound transformation as artificial intelligence (AI), systems biology, and molecular biosciences converge to create integrative frameworks that capture and model biological complexity across multiple scales. Traditional biomedical research has often been constrained by the compartmentalization of biological data, where discoveries at the molecular level rarely translate seamlessly into clinical outcomes. Recent advances in machine learning, multiscale modeling, and high-resolution omics technologies are now breaking these barriers. Landmark studies are demonstrating how integrating genomics, transcriptomics, proteomics, and metabolomics within AI-enabled systems can reveal emergent properties of cells, tissues, and organs.
However, despite this progress, major knowledge gaps persist. These include challenges in unifying heterogeneous datasets, interpreting foundation models in the context of biology, and translating molecular insights into tangible patient benefits. What remains missing is a systematic approach to integrate mechanistic and predictive models that can guide regenerative and individualized therapeutic strategies.
This Research Topic aims to advance the development of AI-driven frameworks that connect molecular biology with systems-level physiology to enable precision and regenerative medicine. The goal is to highlight computational and experimental approaches that bridge molecular mechanisms, disease modeling, and therapeutic design. Key questions include how multimodal data and large-scale foundation models can inform biological understanding, how cell and tissue regeneration can be computationally optimized, and how mechanistic knowledge can be embedded in predictive models to enhance diagnosis, treatment response, and long-term health outcomes. By bringing together systems biology, synthetic biology, and artificial intelligence, this topic seeks to enable a new generation of biology-driven medicine in which predictive models not only describe disease progression but also actively guide precise, durable interventions.
To gather further insights in the intersection of artificial intelligence, systems biology, and translational medicine, we welcome articles addressing, but not limited to, the following themes:
o Multimodal, multiscale, and foundation models for biological systems o Single-cell and spatial omics integration for personalized and regenerative health o Discovery of biomarkers and therapeutic targets using AI-augmented workflows o Data-driven design of engineered cell and gene therapies o Computational-experimental frameworks for regenerative and precision medicine o AI-assisted interpretation of molecular mechanisms underlying therapy response and aging
Article types and fees
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
Brief Research Report
Case Report
Clinical Trial
Community Case Study
Conceptual Analysis
Data Report
Editorial
FAIR² Data
FAIR² DATA Direct Submission
Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.
Article types
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
Brief Research Report
Case Report
Clinical Trial
Community Case Study
Conceptual Analysis
Data Report
Editorial
FAIR² Data
FAIR² DATA Direct Submission
General Commentary
Hypothesis and Theory
Methods
Mini Review
Opinion
Original Research
Perspective
Policy and Practice Reviews
Policy Brief
Review
Study Protocol
Systematic Review
Technology and Code
Keywords: Artificial intelligence, systems biology, precision medicine, regenerative medicine, multiscale modeling, multi-omics integration, foundation models, single-cell omics, biomarker discovery, computational drug design
Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.